23 May 2013
Keywords: Regenerative medicines, Market forecasts, Chalenges, Visiongain
Article | 12 September 2012
The overall global market for translational regenerative medicine will reach a value of $1.4 billion in 2012. That revenue forecast and others ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.